Terms: = Pancreatic cancer AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280 AND Treatment
5 results:
1. E3 ligase MG53 suppresses tumor growth by degrading cyclin D1.
Fang M; Wu HK; Pei Y; Zhang Y; Gao X; He Y; Chen G; Lv F; Jiang P; Li Y; Li W; Jiang P; Wang L; Ji J; Hu X; Xiao RP
Signal Transduct Target Ther; 2023 Jul; 8(1):263. PubMed ID: 37414783
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer.
Wang L; Liu Z; Liang R; Wang W; Zhu R; Li J; Xing Z; Weng S; Han X; Sun YL
Elife; 2022 Oct; 11():. PubMed ID: 36282174
[TBL] [Abstract] [Full Text] [Related]
3. pancreatic metastasectomy of renal cell carcinoma: a single institution experience.
Cardoso D; Rosales A; Thiel DD; Asbun H; Stauffer JA
Can J Urol; 2022 Feb; 29(1):11020-11023. PubMed ID: 35150225
[TBL] [Abstract] [Full Text] [Related]
4. Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis.
Varbanov HP; Kuttler F; Banfi D; Turcatti G; Dyson PJ
PLoS One; 2019; 14(1):e0211268. PubMed ID: 30695050
[TBL] [Abstract] [Full Text] [Related]
5. Repositioning approved drugs for the treatment of problematic cancers using a screening approach.
Varbanov HP; Kuttler F; Banfi D; Turcatti G; Dyson PJ
PLoS One; 2017; 12(2):e0171052. PubMed ID: 28166232
[TBL] [Abstract] [Full Text] [Related]
